Journal of Clinical and Biomedical Sciences
DOI: 10.58739/jcbs/v16i2.25.346
Year: 2026, Volume: 16, Issue: 2, Pages: 64-68
Case Report
Azlan Mazhar Mohammad Shareef1*, Sobia Afreen2, Naushaba Tazeen3, Ramya Parlikar4, Khatija Shameem5, Idrees A Afroze6
1Undergraduate Student, Deccan College of Medical Sciences, Hyderabad, Telangana, India.
2Assistant Professor, Department of Pathology, Deccan College of Medical Sciences, Hyderabad, Telangana, India.
3Associate Professor, Department of Pathology, Deccan College of Medical Sciences, Hyderabad, Telangana, India.
4Senior Resident, Department of Pathology, Deccan College of Medical Sciences, Hyderabad, Telangana, India.
5Professor, Department of Pathology, Deccan College of Medical Sciences, Hyderabad, Telangana, India.
6Head of Department & Professor, Department of Pathology, Deccan College of Medical Sciences, Hyderabad, Telangana, India.
*Corresponding Author
Email: [email protected]
Received Date:15 September 2025, Accepted Date:20 January 2026, Published Date:15 June 2026
This is a report of Mucinous Adenocarcinoma of the Colon with Synchronous Ovarian Metastasis – Kruckenberg tumour in a young female of low socioeconomic background with deceptive presentation emphasizing the diagnostic complexity and the need for clinical adaptability in resource-constrained settings. A 36-year-old woman (G2P2L2) presented with progressive abdominal pain and a rapidly enlarging mass in the right lumbar region. An ultrasonography was consistent with a high-risk ovarian malignancy (ORADS-5). Due to financial constraints, advanced imaging modalities and tumour marker evaluation were deferred. Staging laparotomy was conducted to evaluate possible malignancy and revealed tumour deposits involving not just the ovaries but the ileum, jejunum, mesentery, and omentum too. Cytoreductive surgery was performed. Histopathology demonstrated mucinous tumour cells with signet rings in the stroma of both the ovaries, and along with immunohistochemistry confirmed the diagnosis of “Primary Mucinous Adenocarcinoma of the Colon with Ovarian Metastasis– Kruckenberg Tumour”. Postoperatively, the patient declined further treatment due to financial limitations.
Keywords: Krukenberg Tumor, Adenocarcinoma, Mucinous, Colorectal Neoplasms, Immunohistochemistry, SATB2 Protein, Human, Developing Countries
1. Luo C, Cen S, Ding G, Wu W. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Communications. 2019; 39 (1). Available from: https://doi.org/10.1186/s40880-019-0361-0
2. Pitt J, Dawson PM. Oophorectomy in women with colorectal cancer. European Journal of Surgical Oncology (EJSO). 1999; 25 (4). Available from: https://doi.org/10.1053/ejso.1999.0671
3. Ganesh K, Shah RH, Vakiani E, Nash GM, Skottowe HP, Yaeger R, <I>et al</I>. Clinical and genetic determinants of ovarian metastases from colorectal cancer. Cancer. 2017; 123 (7). Available from: https://doi.org/10.1002/cncr.30424
4. Lewis MR, Deavers MT, Silva EG, Malpica A.. Ovarian Involvement by Metastatic Colorectal Adenocarcinoma. American Journal of Surgical Pathology. 2006; 30 (2). Available from: https://doi.org/10.1097/01.pas.0000176436.26821.8a
5. Serov Sf, Scully RE, Sobin LH. (1973) <I>Histological Typing of Ovarian Tumours</I>. WHO, Geneva. - references - scientific research publishing [Internet]. Scirp.org. [cited 2025 Dec 3]. Available from: https://www.scirp.org/reference/referencespapers?referenceid=1155828
6. Das S, Sahu D, Wani M, Reddy PK. A curious discourse of Krukenberg tumor: a case report. Journal of Gastrointestinal Oncology. 2014; 5 (6). Available from: http://doi.org/10.3978/j.issn.2078-6891.2014.057
7. Kir G, Gurbuz A, Karateke A, Kir M. Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma. World Journal of Gastrointestinal Surgery. 2010; 2 (4). Available from: https://doi.org/10.4240/wjgs.v2.i4.109
8. Shimazaki J, Tabuchi T, Nishida K, Takemura A, Motohashi G, Kajiyama H, <I>et al</I>. Synchronous ovarian metastasis from colorectal cancer: A report of two cases. Oncology Letters. 2016; 12 (1). Available from: https://doi.org/10.3892/ol.2016.4553
9. Rezk M, Hussein A, Saad Alqahtani A, Farouk A, Bazeed MF, Alqahtani SA, <I>et al</I>. <I>Ovarian metastasis from adenocarcinoma of the rectosigmoid colon</I> [Internet]. E-century.us. 2023 [cited 2025 Dec 3]. Available from: https://e-century.us/files/ijcem/16/7/ijcem0148856.pdf
10. Kim A, Ueda Y, Naka T, Enomoto T. Therapeutic strategies in epithelial ovarian cancer. Journal of Experimental & Clinical Cancer Research. 2012; 31 (1). Available from: https://doi.org/10.1186/1756-9966-31-14
11. Annal A, Sadath SA. Krukenberg Tumour in Adolescents: Rare but Possible. The Journal of Obstetrics and Gynecology of India. 2022; 72 (5). Available from: https://doi.org/10.1007/s13224-020-01414-5
12. Parmar R, Davda M, Patel N, Patel KA. Krukenberg tumor in a young female arising from a primary adenocarcinoma of stomach: a case report. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2021; 10 (6). Available from: https://doi.org/10.18203/2320-1770.ijrcog20212209
13. Spinelli C, Liloia C, Piscioneri J, Ugolini C, Strambi S. An Unusual Evolution of Krukenberg Tumour: A Case Report. Journal of Clinical and Diagnostic Research. 2016; 10 (10). Available from: https://doi.org/10.7860/jcdr/2016/20299.8747
14. Zulfiqar M, Koen J, Nougaret S, Bolan C, VanBuren W, McGettigan M, <I>et al</I>. Krukenberg Tumors: Update on Imaging and Clinical Features. American Journal of Roentgenology. 2020; 215 (4). Available from: https://doi.org/10.2214/ajr.19.22184
15. Aziz M, Killeen RB, Carlson K, Kasi A. Krukenberg tumor. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
16. Chen Z, Liu Z, Yang J, Sun J, Wang P. The clinicopathological characteristics, prognosis, and CT features of ovary metastasis from colorectal carcinoma. Translational Cancer Research. 2021; 10 (7). Available from: https://doi.org/10.21037/tcr-21-605
17. Ionescu O, Balescu I, Bacalbasa N. Krukenberg tumors. Prognostic factors, surgical treatment and survival benefit. A literature review. Gineco.eu. 2016; 12 (4). Available from: https://doi.org/10.18643/gieu.2016.202
18. Cho JH, Lim JY, Choi AR, Choi SM, Kim JW, Choi SH, <I>et al</I>. Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor. Cancer Research and Treatment. 2014; 47 (4). Available from: https://doi.org/10.4143/crt.2013.175
19. Fillmann LS, Fillmann HS, Fillmann LP, Tubiana APR, Ribeiro R, Coelho M. Ovarian Metastasis from Colorectal Adenocarcinoma. Journal of Coloproctology. 2021; 41 (02). Available from: https://doi.org/10.1055/s-0041-1730426
20. Kolak A, Lozinski M, Mandziuk S. Systemic treatment of Krukenberg tumors. Current Issues in Pharmacy and Medical Sciences. 2017; 30 (4). Available from: https://doi.org/10.1515/cipms-2017-0033
21. Xu KY, Gao H, Lian ZJ, Ding L, Li M, Gu J. Clinical analysis of Krukenberg tumours in patients with colorectal cancer—a review of 57 cases. World Journal of Surgical Oncology. 2017; 15 (1). Available from: https://doi.org/10.1186/s12957-016-1087-y
22. Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. American Journal of Surgical Pathology. 2016; 40 (3). Available from: https://doi.org/10.1097/pas.0000000000000553
23. Tornillo L, Moch H, Diener PA, Lugli A, Singer G. CDX-2 immunostaining in primary and secondary ovarian carcinomas. Journal of Clinical Pathology. 2004; 57 (6). Available from: https://doi.org/10.1136/jcp.2003.013615
24. Choi BJ, Kim CJ, Cho YG, Song JH, Kim SY, Nam SW, <I>et al</I>. Altered expression of CDX2 in colorectal cancers. APMIS. 2006; 114 (1). Available from: https://doi.org/10.1111/j.1600-0463.2006.apm_292.x
25. Salim S, Asif M, Ahmed R, Din HU, Khadim MT, Sadaf G. Diagnostic utility of satb2 in metastatic colorectal carcinoma. Pakistan Armed Forces Medical Journal. 2021; 71 (Suppl-1). Available from: https://doi.org/10.51253/pafmj.v71isuppl-1.3034
26. Chiesa-Vottero A. CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors. International Journal of Gynecological Pathology. 2020; 39 (2). Available from: https://doi.org/10.1097/pgp.0000000000000582
27. Yang C, Sun L, Zhang L, Zhou L, Zhao M, Peng Y, <I>et al</I>. Diagnostic Utility of SATB2 in Metastatic Krukenberg Tumors of the Ovary. American Journal of Surgical Pathology. 2018; 42 (2). Available from: https://doi.org/10.1097/pas.0000000000000951
28. Ma C, Olevian D, Miller C, Herbst C, Jayachandran P, Kozak MM, <I>et al</I>. SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer. Modern Pathology. 2019; 32 (8). Available from: https://doi.org/10.1038/s41379-019-0265-1
29. Li J, Zeng Q, Lin J, Huang H, Chen L. Loss of SATB2 and CDX2 expression is associated with DNA mismatch repair protein deficiency and BRAF mutation in colorectal cancer. Medical Molecular Morphology. 2024; 57 (1). Available from: https://doi.org/10.1007/s00795-023-00366-9
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Published By Sri Devaraj Urs Academy of Higher Education, Kolar, Karnataka
Subscribe now for latest articles and news.
